Status:

UNKNOWN

Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis

Lead Sponsor:

Radboud University Medical Center

Conditions:

Carcinoma, Non Small Cell Lung

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

CT-PET image fusion has the potential to differentiate 'tumor' from 'atelectasis' much better than the CT-scan in patients with non-small cell lung cancer who also have atelectasis. This however has ...

Eligibility Criteria

Inclusion

  • Patients with non small cell lung cancer and atelectasis, who are eligible for surgery.

Exclusion

  • age \< 18 years
  • pregnancy

Key Trial Info

Start Date :

June 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00184964

Start Date

June 1 2004

Last Update

June 4 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboud University Nijmegen Medical Centre

Nijmegen, Gelderland, Netherlands, 6500HB

Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis | DecenTrialz